Imaging and Evolution of Pigmented Tumors of the Anterior Ocular System in Children
NCT ID: NCT07120178
Last Updated: 2025-08-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
53 participants
OBSERVATIONAL
2025-04-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The challenge is to be able to adapt the child's follow-up according to the imaging and avoid an invasive procedure such as surgical excision if the imaging does not find any suspicious cells despite a change in size or colour. This would also make it possible to answer parents' questions about the potential evolution of the tumour. Finally, it would enable the frequency of monitoring to be personalised according to the data analysed. The tests are all non-invasive and painless.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dermoscopic Monitoring of Pediatric Melanocytic Nevi Regarding Pattern and Diameter Changes
NCT05463510
Ophthalmological Screening and Follow-up of Optic Pathway Gliomas in Children With Neurofibromatosis Type 1.
NCT02078401
Molecular Analysis of Retinoblastoma
NCT00718783
Quality of Life and Stigmatization in Children with Congenital Melanocytic Nevi Before and After Nevus Excision
NCT02280889
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
NCT01771718
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Observational group
Children with pigmented tumors of the anterior ocular system
slit lamp examination
data collected: tumor size, pigmentation, vascularization, cells
dermatoscopy examination x20 and x400
data collected: tumor size, pigmentation, vascularization, cells
confocal microscopy examination
data collected: tumor size, pigmentation, vascularization, cells
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
slit lamp examination
data collected: tumor size, pigmentation, vascularization, cells
dermatoscopy examination x20 and x400
data collected: tumor size, pigmentation, vascularization, cells
confocal microscopy examination
data collected: tumor size, pigmentation, vascularization, cells
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean Luc PERROT, Md, PhD
Role: PRINCIPAL_INVESTIGATOR
CHU SAINT-ETIENNE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Saint-Etienne
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRBN222025/CHUSTE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.